SilcsBio, LLC Announces Release of CGenFF 2.3.0
Baltimore, MD, 26 April, 2019 In ongoing efforts to improve the coverage of the CGenFF program, version 2.3.0 of the CGenFF program improves support for a variety of molecules via explicit parametrization of the molecules outlined below and features improvements for halogen-protein interactions. Molecules explicitly parametrized The functional groups in these molecules were previously accessible […]
Sygnature Discovery announces collaboration with software firm SilcsBio
SilcsBio, LLC Receives NIH Funding to Expand Offerings in Biologics
FOR IMMEDIATE RELEASE: April 11, 2019 Ken Malone SilcsBio, LLC 410.929.2305 Ken.Malone@silcsbio.com SilcsBio, LLC Receives NIH Funding to Expand Offerings in Biologics Baltimore, Maryland: SilcsBio, LLC announced today a $225,000 award from the National Institutes of Health to expand on its broadly used software, SILCS, to enable its use with biological therapeutics, especially for […]
Ranking Reversible Covalent Drugs: From Free Energy Perturbation to Fragment Docking
Exploring protein-protein interactions using the Site-Identification by Ligand Competitive Saturation (SILCS) methodology
No opportunities available
SilcsBio has no job openings at this time. Please check back again.